21-Gene Recurrence Assay Associated With Favorable Metabolic Profiles in HR-Positive, HER2-Negative Early-Stage Breast Cancer Patients

21-Gene Recurrence Assay Associated With Favorable Metabolic Profiles in HR-Positive, HER2-Negative Early-Stage Breast Cancer Patients

BackgroundComprehensive investigations of the associations between 21-gene recurrence assay and metabolic profiles in Chinese breast cancer patients are limited.MethodsWe evaluated the relations of the 21-gene recurrence risk score (RS) and the expression of cancer-related genes with metabolic facto...

Full description

Bibliographic Details
Main Authors: Yifei Zhu, Tiange Wang, Yiwei Tong, Xiaosong Chen, Kunwei Shen
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-08-01
Series:Frontiers in Endocrinology
Subjects:
21-gene recurrence score assay
cancer-related genes
metabolic profile
breast cancer
Chinese women
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2021.725161/full

Internet

https://www.frontiersin.org/articles/10.3389/fendo.2021.725161/full

Similar Items